MedLife S.A. strengthens its leadership position in advanced diagnostics through the acquisition of a majority stake in Qualipat The MedLife Group acquires 75% of Qualipat and expands its expertise in pathology, immunohistochemistry, and molecular diagnostics. The partnership opens a new stage of development focused on digital pathology, the integration of oncology biomarkers, and the use of artificial intelligence technologies to support medical decision-making. For patients, the integration of... Sursa: Nineoclock https://nineoclock.ro/medlife-strengthens-its-leadership-position-in-advanced-diagnostics-through-the-acquisition-of-a-majority-stake-in-qualipat/